论文信息 - The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax - 字舞流文

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

D. Fabbro | L. Cascione | A. Stathis | E. Gaudio | M. Wymann | Vladimir Cmiljanović | E. Zucca | F. Beaufils | L. Aresu | I. Kwee | F. Bertoni | C. Tarantelli | Petra Hillmann | F. Spriano | Denise Rageot | G. Sartori